Advanced Search

Oncology & Hematology Coding Alert

Reader Question:

J9355 Isn't Subject to 'Wasted Drug' Payment

Published on Thu Sep 13, 2012

Question: Palmetto is doing a review of J9355 claims because people are reporting units incorrectly. What is the appropriate way to report units for multi-use vials?South Carolina SubscriberAnswer: For multi-use vials, you should report units based on the amount of drug administered to the patient. So if the patient receives 188 mg of Herceptin, you should report 19 units of J9355 (Injection, trastuzumab, 10 mg). Divide 188 mg by the 10 mg in the code definition to get 18.8. Then round up to get 19 units. (See Medicare Claims Processing Manual [MCPM], Chapter 17, Section 10, for more information: www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c17.pdf). Key point: You should report only the amount actually administered. Multi-use vials are not subject to payment for discarded amounts of drug or biological, according to MCPM, Chapter 17, Section 40. You should bill wastage only for amounts not used from single-dose vials (SDV) or packages.More details: Palmetto announced [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All